Recital 24, Regulation (EU) 2025/1489

In forcesince 24 Jul 2025

Commission Implementing Regulation (EU) 2024/324 [Commission Implementing Regulation (EU) 2024/324 of 19 January 2024 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L, 2024/324, 22.1.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/324/oj).] extended the approval period of the active substance pyraclostrobin until 15 September 2025, and the approval period of the active substance buprofezin until 15 December 2025.